Simon Veedfald1,2, Tongzhi Wu1, Michelle Bound1, Jacqueline Grivell1, Bolette Hartmann2,3, Jens F Rehfeld4, Carolyn F Deacon2,3, Michael Horowitz1, Jens J Holst2,3, Christopher K Rayner1. 1. Discipline of Medicine and National Health and Medical Research Council Centre of Research Excellence in Nutritional Physiology, Interventions and Outcomes, University of Adelaide, Adelaide, South Australia, Australia. 2. Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. 3. Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. 4. Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
Abstract
Context: The mechanisms regulating the postprandial suppression of ghrelin secretion remain unclear, but recent observations in rats indicate that an increase in duodenal osmolarity is associated with a reduction in ghrelin levels. Several hormones have been implicated in the regulation of ghrelin. Objective: We hypothesized that intraduodenal infusion of a hyperosmolar solution would lower plasma ghrelin concentrations. Design, Setting, Participants, and Interventions: Eighteen healthy young men were studied after an overnight fast on two occasions in a randomized double-blinded fashion. A nasoduodenal catheter was positioned and isoosmolar (300 mOsm/L) or hyperosmolar (1500 mOsm/L) saline was infused intraduodenally (4 mL/min, t = 0 to 45 minutes). Venous blood was sampled at t = -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 120, and 180 minutes. Main Outcome Measures: Plasma concentrations of ghrelin, glucagonlike peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), cholecystokinin (CCK), glucagon, pancreatic polypeptide (PP), neurotensin (NT), peptide YY (PYY), motilin, and glucose. Results:Ghrelin concentrations were suppressed with hyperosmolar when compared with isoosmolar saline, and remained lower until t = 180 minutes. CCK, NT, GLP-1, PYY, and glucagon all increased during hyperosmolar, but not isoosmolar, saline infusion (P < 0.01 for all), whereas GIP, PP, and motilin levels were not affected by either infusion. Conclusions: Plasma ghrelin concentrations are lowered, whereas CCK, GLP-1, PYY, NT, and glucagon concentrations are augmented, by hyperosmolar duodenal content in healthy individuals. These observations have implications for the evaluation of studies comparing the effects of different types and loads of nutrients and chemicals on gut hormone secretion.
RCT Entities:
Context: The mechanisms regulating the postprandial suppression of ghrelin secretion remain unclear, but recent observations in rats indicate that an increase in duodenal osmolarity is associated with a reduction in ghrelin levels. Several hormones have been implicated in the regulation of ghrelin. Objective: We hypothesized that intraduodenal infusion of a hyperosmolar solution would lower plasma ghrelin concentrations. Design, Setting, Participants, and Interventions: Eighteen healthy young men were studied after an overnight fast on two occasions in a randomized double-blinded fashion. A nasoduodenal catheter was positioned and isoosmolar (300 mOsm/L) or hyperosmolar (1500 mOsm/L) saline was infused intraduodenally (4 mL/min, t = 0 to 45 minutes). Venous blood was sampled at t = -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 120, and 180 minutes. Main Outcome Measures: Plasma concentrations of ghrelin, glucagonlike peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), cholecystokinin (CCK), glucagon, pancreatic polypeptide (PP), neurotensin (NT), peptide YY (PYY), motilin, and glucose. Results:Ghrelin concentrations were suppressed with hyperosmolar when compared with isoosmolar saline, and remained lower until t = 180 minutes. CCK, NT, GLP-1, PYY, and glucagon all increased during hyperosmolar, but not isoosmolar, saline infusion (P < 0.01 for all), whereas GIP, PP, and motilin levels were not affected by either infusion. Conclusions: Plasma ghrelin concentrations are lowered, whereas CCK, GLP-1, PYY, NT, and glucagon concentrations are augmented, by hyperosmolar duodenal content in healthy individuals. These observations have implications for the evaluation of studies comparing the effects of different types and loads of nutrients and chemicals on gut hormone secretion.
Authors: Amalie R Lanng; Lærke S Gasbjerg; Natasha C Bergmann; Sigrid Bergmann; Mads M Helsted; Matthew P Gillum; Bolette Hartmann; Jens J Holst; Tina Vilsbøll; Filip K Knop Journal: Endocr Connect Date: 2019-10 Impact factor: 3.335
Authors: Daniel R Crabtree; William Buosi; Claire L Fyfe; Graham W Horgan; Yannis Manios; Odysseas Androutsos; Angeliki Giannopoulou; Graham Finlayson; Kristine Beaulieu; Claire L Meek; Jens J Holst; Klaske Van Van Norren; Julian G Mercer; Alexandra M Johnstone Journal: Nutrients Date: 2020-11-30 Impact factor: 5.717
Authors: Anne Christin Meyer-Gerspach; Jürgen Drewe; Wout Verbeure; Carel W le Roux; Ludmilla Dellatorre-Teixeira; Jens F Rehfeld; Jens J Holst; Bolette Hartmann; Jan Tack; Ralph Peterli; Christoph Beglinger; Bettina K Wölnerhanssen Journal: Nutrients Date: 2021-01-08 Impact factor: 5.717
Authors: Bettina K Wölnerhanssen; Jürgen Drewe; Wout Verbeure; Carel W le Roux; Ludmilla Dellatorre-Teixeira; Jens F Rehfeld; Jens J Holst; Bolette Hartmann; Jan Tack; Ralph Peterli; Christoph Beglinger; Anne C Meyer-Gerspach Journal: Diabetes Obes Metab Date: 2021-02-26 Impact factor: 6.577
Authors: Wei-Kun Huang; Cong Xie; Richard L Young; Jiang-Bo Zhao; Heike Ebendorff-Heidepriem; Karen L Jones; Christopher K Rayner; Tong-Zhi Wu Journal: World J Gastroenterol Date: 2020-07-07 Impact factor: 5.742
Authors: Ali Asmar; Per K Cramon; Meena Asmar; Lene Simonsen; Charlotte M Sorensen; Sten Madsbad; Cedric Moro; Bolette Hartmann; Jens F Rehfeld; Jens J Holst; Peter Hovind; Boye L Jensen; Jens Bülow Journal: Physiol Rep Date: 2020-08